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Background: BCG vaccination is recommended at birth in low-income countries, but vaccination is often delayed. Often
20-dose vials of BCG are not opened unless at least ten children are present for vaccination (“restricted vial-opening
policy”). BCG coverage is usually reported as 12-month coverage, not disclosing the delay in vaccination. Several studies
show that BCG at birth lowers neonatal mortality. We assessed BCG coverage at different ages and explored reasons for
delay in BCG vaccination in rural Guinea-Bissau.
Methods: Bandim Health Project (BHP) runs a health and demographic surveillance system covering women and their
children in 182 randomly selected village clusters in rural Guinea-Bissau. BCG coverage was assessed for children born
in 2010, when the restricted vial-opening policy was universally implemented, and in 2012–2013, where BHP provided
BCG to all children at monthly visits in selected intervention regions. Factors associated with delayed BCG vaccination
were evaluated using logistic regression models. Coverage between intervention and control regions were evaluated
in log-binomial regression models providing prevalence ratios.
Results: Among 3951 children born in 2010, vaccination status was assessed for 84%. BCG coverage by 1 week of age
was 11%, 38% by 1 month, and 92% by 12 months. If BCG had been given at first contact with the health system, 1-week
coverage would have been 35% and 1-month coverage 54%. When monthly visits were introduced in intervention
regions, 1-month coverage was higher in intervention regions (88%) than in control regions (51%), the prevalence ratio
being 1.74 (1.53-2.00). Several factors, including socioeconomic factors, were associated with delayed BCG vaccination in
the 2010-birth cohort. When BCG was available at monthly visits these factors were no longer associated with delayed
BCG vaccination, only region of residence was associated with delayed BCG vaccination.
Conclusion: BCG coverage during the first months of life is low in Guinea-Bissau. Providing BCG at monthly vaccination
visits removes the risk factors associated with delayed BCG vaccination.
Keywords: BCG, Coverage, Timeliness of vaccines, Implementation of the vaccination programmeBackground
Bacillus Calmette Guérin (BCG) vaccine is recommended
at birth to normal-birth-weight children in Guinea-Bissau.
However, BCG vaccination is often delayed for several rea-
sons, one of them being the “restrictive vial-opening pol-
icy”: BCG is a freeze-dried vaccine supplied in vials with 20
infant doses [1] and once reconstituted, the vaccine should
only be used for a maximum of six hours. In Guinea-Bissau* Correspondence: smthysen@gmail.com
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unless otherwise stated.and other low-income countries [2,3], the focus on not
wasting vaccines [4] has led to a policy of not opening a
BCG vial unless 10 children are present to be vaccinated
[5]. Previous studies have shown that BCG has beneficial
non-specific or heterologous effects, providing protection
also against many non-tuberculosis causes of death [6-15].
In two randomised trials among low-birth-weight (<2500 g,
LBW) neonates, BCG at birth compared with the usual
delayed BCG, lowered neonatal mortality by 48% (95% CI:
18%-67%) [6,7], the reduction being 58% (8%-81%) the first
three days after vaccination [6,7]. The rapidly occurring ef-
fect suggests that BCG stimulates the innate immune sys-
tem. This is supported by recent immunological studiesLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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gram monocytes to increased pro-inflammatory responses
against unrelated pathogens [16,17].
Most infant deaths occur during the neonatal period, par-
ticularly in the first week of life [18] and thus any delays in
BCG vaccination may have major consequences because
children do not benefit from BCG when their mortality risk
is highest. Hence, it is important to identify obstacles to
early BCG vaccination, as this will help target interventions
to lower the age at vaccination.
We assessed BCG coverage at different ages among chil-
dren born in 2010 in rural Guinea-Bissau to identify fac-
tors associated with delayed BCG vaccination in a context
with a restrictive vial-opening policy. In 2012, we imple-
mented monthly visits and provided BCG vaccination to
newborns in three intervention regions (Oio, Biombo and
Cacheu) but not in six control regions. We evaluated how
not adhering to the restrictive vial-opening policy affected
BCG coverage and affected factors associated with delayed
BCG vaccination.
Methods
Setting and study population
The study was conducted in the rural study area of the
Bandim Health Project (BHP) in Guinea-Bissau. The BHP
maintains a health and demographic surveillance system
following 182 randomly selected clusters of 100 women
and their children in rural Guinea-Bissau. The clusters were
initially selected using the Expanded Programme on Immu-
nizations (EPI) methodology for immunisation surveys
sampling 20 clusters of 100 women in each of the eight lar-
ger health regions, and 10 and 12 clusters in the two smal-
lest regions. Later two regions have been joined and rural
Guinea-Bissau now has nine health regions; Oio, Biombo,
Gabu, Cacheu, Bafata, Quinara, Tombali, Bubaque, and
Bolama. All women of fertile age and children below the
age of 5 years are followed through home visits every four
to six months.
At the home visits women of fertile age are registered
and information on ethnicity and schooling is collected. If
a pregnancy is registered, a special form is completed col-
lecting information on prenatal consultations and socio-
economic factors. For all newborn children information
on date of birth, place of birth, and prenatal consultations
is collected. At all visits the child’s vaccination card is
inspected and vaccination dates are recorded. If the child
has no vaccination card a vaccination card is provided
from the BHP team.
BCG vaccination possibilities
Children in Guinea-Bissau should receive BCG and oral
polio vaccine (OPV) at birth, pentavalent vaccine (diph-
theria-tetanus-pertussis-H. influenza type B-Hepatitis B
vaccine) and OPV at 6, 10, and 14 weeks, and measles andyellow fever vaccines at 9 months. These vaccines are pro-
vided free of charge at the health centres as part of the na-
tional programme and during outreach to villages when
additional funding is available. Due to the restricted vial-
opening policy some vaccines are only provided once a
week at health centres and only if there is a sufficient num-
ber of eligible children present.
Since 2007 the BHP teams visiting the surveyed villages
in all regions have been accompanied by a nurse, who
offered OPV, pentavalent vaccine, measles vaccine, and
yellow fever vaccine to all children below the age of 1
year. The vaccines were supplied through the national
programme and the BHP nurse had to follow the national
policy. Hence she did not bring BCG as she would very
rarely encounter sufficient eligible children in a village.
In 2012 the BHP increased the frequency of visits from
four-six-monthly visits to monthly visits in three regions
(Oio, Biombo and Cacheu). In these intervention regions
BCG vaccination was offered to all children below the age
of 1 year regardless of the number of children present, thus
a BCG vial was opened for one child. In the remaining con-
trol regions national policy was followed and BCG was not
offered during village visits.
Information about reasons for delay of BCG vaccination
During the year from 1st July 2012 to 30th June 2013
mothers of BCG unvaccinated infants in all regions were
interviewed on their BCG vaccination attempts/experiences
during home visits. They were asked if they knew that their
child was due to receive BCG and whether they had taken
the child for vaccination. Mothers who reported to have
sought vaccination were asked why the child had not been
vaccinated. Mothers who had not sought BCG vaccination
were interviewed about the reasons.
Ethical approval
BHP’s HDSS which has been in place in Guinea-Bissau
since 1978 and is conducted by request from the Guinean
Ministry of Health. The current surveillance system in the
rural areas has been approved by the National Ethics Com-
mittee in Guinea-Bissau and the Central Ethics Committee
in Denmark. No separate ethical and consent approval was
sought.
Statistical analyses
Assessing BCG coverage in the 2010-birth cohort
Standard estimates for vaccination coverage are usually
based on vaccinations obtained by 12 months of age,
assessed among children aged 12 to 23 months [19,20].
In the 2010-birth cohort we assessed BCG coverage by 1
month of age in children aged 1–12 months at the time
of the home visit, the coverage by 3 months of age in
children aged 3–14 months, the coverage by 6 months
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months in children aged 12–23 months (Table 1). Since
most neonatal deaths occur within the first week of life,
we also assessed the 1-week coverage using vaccination
status assessed within the 12 months after day 7. Vaccin-
ation status was determined at the first visit in the rele-
vant time period at which the vaccination card was seen.
Children who had lost their vaccination card or for
whom the vaccination card was not seen were excluded
from the analysis.
Missed opportunities among BCG unvaccinated children
were defined as contact with the health system, either being
born at a health facility or having received other vaccines
(based on the registered date of another vaccination on the
vaccination card). We calculated the potential coverage if
BCG had been given at the first contact with the health
system.
Assessing BCG coverage after implementation of
monthly visits, 2012 cohort
In 2012 monthly visits were introduced in the intervention
regions, whereas four-six-monthly visits continued in con-
trol regions. We considered a village as belonging to the
intervention regions when there was less than 6 weeks be-
tween two subsequent visits. BCG coverage was assessed
among all children visited from 1st July 2012 to 30th June
2013. Like in the 2010-birth cohort, we assessed BCG cover-
age at 1, 3, 6, and 12 months of age. To take into account
that children in intervention regions with monthly visits had
a larger possibility of having their card seen within a 12
months period compared with children in control regions
with four-six-monthly visits, we considered only data col-
lected in the month after 1, 3, 6, and 12 months, respectively
(Table 1).
Comparisons of coverage between regions with different
BCG provision strategies were evaluated in log-binomial
regression models providing prevalence ratios (PR).
Factors associated with delayed BCG vaccination
Factors associated with delayed BCG vaccination (vac-
cination after 1 month of age) were assessed in the
2010-birth cohort and after implementation of monthly
visits separately for intervention and control regions in
2012/2013. This study focused on background factors
assessed among the users of the vaccination services. TheTable 1 Coverage assessment methods for standard coverage
cohort and the 2012 cohort
Standard coverage estimates Coverage in 2010-bir
Children Children born in 2010
Assessment ages 12 months 1 week, 1, 3, 6 and 12
Vaccination status 12-23 months First visit with seen vac
card within 12 monthsfactors evaluated were: sex, birth place, antenatal care, re-
gion, type of roof, toilet, household possessions (radio, cell
phone, and generator), ethnic group (Fula, Pepel, Balanta,
Manjaco, and other), age of mother, and education of
caretaker. All continuous variables were tested for linear
relationship with BCG coverage by inspecting the BCG
coverage in quintiles of the variable. Where inspection
suggested a linear relationship, the quadratic value of the
continuous variable was included in the model to assess
departure from linearity. We tested all variables one by
one in a simple model using logistic regression to calcu-
late the odds ratio (OR) of being unvaccinated. As chil-
dren were not individually sampled but selected for the
study based on residence within a geographical cluster, we
adjusted the standard error for cluster. In a larger multi-
variable model we included all factors associated with de-
layed BCG. In this large model we excluded ethnic group
since ethnic group and region were highly correlated with
more than 90% of the Pepels living in Biombo, and more
than 75% of the Manjacos living in Cacheu. We chose to
include region rather than ethnicity since region would be
feasible to target through interventions.
Results
BCG coverage in the 2010-birth cohort
We assessed vaccination status at a visit within the first 2
years of life for 84% (3318/3951) of all children (Additional
file 1). In the 2010-birth cohort, the BCG coverage by 1
week of age was 11% (327/3020) and 38% (1140/2984) by 1
month of age but increased to 92% (2385/2594) coverage
by 12 months of age (Figure 1). If all children had re-
ceived BCG vaccine at their first contact with the
healthcare system, coverage would have been at least
35% by 1 week of age, 54% by 1 month of age and 99%
by 12 months of age (Figure 1). The median age of BCG
vaccination among children vaccinated within the first
12 months of life was 39 days. This could be reduced to
27 days if BCG vaccine had been given at first contact
with the healthcare system.
BCG coverage after implementation of monthly visits,
2012 cohort
In the 2010-birth cohort, BCG coverage did not differ
significantly between the regions which subsequently be-
came intervention regions compared with the controlestimates and coverage estimates in the 2010-birth
th cohort Coverage in 2012 cohort
Children aged 1, 3, 6, or 12 months of age,
when visited from 1st July 2012 to 30th June 2013
months 1, 3, 6, and 12 months
cination
after assessment age
Visit with seen vaccination card in the month
after the assessment age
Figure 1 Observed BCG coverage and potential BCG coverage by different ages. Observed BCG coverage (blue) and potential BCG
coverage if all vaccination opportunities had been used (purple). Bandim Health Project, Guinea-Bissau, 2010-birth cohort.
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plementation of monthly visits, we assessed BCG coverage
among a total of 2812 children (Additional file 2). Cover-
age by 1 month of age was 88% (769/872) in intervention
regions and 51% (141/279) in control regions (Figure 2),
the PR being 1.74 (1.53-2.00). The 3-months coverage was
99% (769/776) in intervention regions and 85% (304/359)
in control regions. By 12 months of age, it had increased
to 99% (257/259) in intervention regions and 95% (284/
299) in control regions. The potential 1-month coverage if
BCG vaccine had been given at first contact with the
healthcare system was 93% in intervention regions and
65% in control regions.
Factors associated with delayed BCG vaccination in the
2010-birth cohort
A number of factors were associated with being BCG vac-
cinated by 1 month of age (Table 2). Region of residence
was strongly associated; only 25% of children in Oio had
received BCG compared with 60% on Bolama. Caretaker’s
education was significantly associated with delayed BCG
vaccination in both the univariate analysis (OR = 1.15
(1.10-1.20) per year of schooling), and the multivariable
analysis (OR = 1.07 (1.02-1.12)). Previous contact with the
health system was associated with higher BCG coverage in
both the univariate and the multivariable analysis: Chil-
dren born at health centres or hospitals were more likely
to be BCG vaccinated (OR = 1.70 (1.26-2.30) and OR =Figure 2 Observed BCG coverage by different ages in intervention an2.88 (2.06-4.01), respectively) than children born at home.
Also, children of mothers who attended prenatal consult-
ation were more likely to be BCG vaccinated (OR = 1.78
(1.23-2.57). The children born to mothers with better eco-
nomic status reflected in possession of a latrine and pos-
session of a cell phone had higher coverage; however,
other socioeconomic factors were not significantly associ-
ated with coverage in the multivariable analysis. Maternal
age was not associated with BCG coverage, and finally
BCG coverage did not differ significantly for girls com-
pared with boys (OR = 1.19 (0.99-1.43)) (Table 2).
The risk factor analysis for BCG coverage by 3, 6, and 12
months identified the same factors but most associations
were weaker. Prenatal consultation was significantly associ-
ated with BCG coverage at all ages (data not shown).
Factors associated with delayed BCG vaccination after
implementation of monthly visits, 2012 cohort
After implementation of monthly visits, factors associated
with delayed BCG vaccination were studied among the
2812 children who had a vaccination status assessed by 1,
3, 6, or 12 months of age. In the control regions
(n = 1147) the factors strongest associated with being
BCG vaccinated by 1 month of age in the 2012 cohort
were region, contact with the healthcare system (being
born at a hospital; OR = 1.81 (1.20-2.73)), and living in a
house with hard roof (OR = 1.74 (1.30-2.32)). Other fac-
tors were significantly associated with delayed BCG in thed control regions. Bandim Health Project, Guinea-Bissau, 2012 cohort.
Table 2 Factors associated with BCG vaccination by 1 month of age
Total number
of children
BCG by 1 month n (%) OR of BCG vaccination1 Multivariable analysis OR (95%CI)1 P-value for the univariate/multivariable analyses
Gender 0.202/0.063
Male 1493 553 (37) Ref Ref
Female 1491 587 (39) 1.10 (0.95-1.28) 1.19 (0.99-1.43)
Age of mother2 0.616/0.662
1.quartile (<21) 763 304 (40) Ref Ref
2. quartile (21–24) 614 239 (39) 0.96 (0.77-1.21) 1.06 (0.80-1.40)
3. quartile (25–30) 825 306 (37) 0.89 (0.71-1.11) 1.08 (0.82-1.43)
4. quartile (>30) 745 275 (37) 0.88 (0.71-1.10) 1.18 (0.90-1.55)
Education of caretaker3,4 <0.001/0.006
None 1889 627 (33) 1.15 (1.10-1.20) 1.07 (1.02-1.12)
1-4 years 648 286 (44)
5+ years 347 185 (53)
Region5 <0.001/0.007
Oio 416 102 (25) 0.37 (0.21-0.64) 0.39 (0.21-0.73)
Biombo 445 183 (41) 0.79 (0.50-1.24) 0.90 (0.60-1.35)
Gabu 459 132 (29) 0.45 (0.28-0.75) 0.50 (0.30-0.82)
Cacheu 582 274 (47) Ref Ref
Bafata 370 122 (33) 0.55 (0.31-0.98) 0.49 (0.27-0.89)
Quinara 277 143 (52) 1.20 (0.69-2.09) 1.07 (0.61-1.87)
Tombali 277 105 (38) 0.69 (0.46-1.03) 0.84 (0.55-1.29)
Bubaque 86 36 (42) 0.81 (0.46-1.42) 0.50 (0.24-1.01)
Bolama 72 43 (60) 1.67 (0.98-2.84) 0.59 (0.33-1.04)
Ethnic group6 <0.001/NA
Balanta 739 265 (36) 1.27 (0.88-1.82)
Mandinga/Fula 1116 342 (31) Ref
Manjaco 254 149 (59) 3.21 (1.89-5.44)
Pepel 391 151 (39) 1.42 (0.92-2.20)
Other 481 231 (48) 2.09 (1.46-2.99)
Contact with the health system
Birth place7 <0.001/<0.001



















Table 2 Factors associated with BCG vaccination by 1 month of age (Continued)
Healthcare centre 527 263 (50) 2.27 (1.68-3.07) 1.70 (1.26-2.30)
Hospital 380 228 (60) 3.42 (2.61-4.48) 2.88 (2.06-4.01)
Other 29 4 (14) 0.36 (0.13-1.02) 0.43 (0.16-1.18)
Prenatal consultations8 .001/0.002
Yes 2313 942 (41) 2.88 (2.06-4.02) 1.78 (1.23-2.57)
No 301 58 (19) Ref Ref
Socioeconomics
Type of roof9 .001/0.324
Straw 1427 482 (34) Ref Ref
Hard 1522 649 (43) 1.46 (1.17-1.81) 1.13 (0.89-1.43)
Toilet10 001/0.005
None 903 286 (32) Ref Ref
Latrine/ toilet in house 2037 839 (41) 1.51 (1.18-1.94) 1.54 (1.14-2.08)
Household possessions
Cell phone11 .001/0.025
Yes 1339 571 (43) 1.41 (1.20-1.64) 1.24 (1.03-1.49)
No 1575 545 (35) Ref Ref
Radio12 11/0.192
Yes 2104 825 (39) 1.13 (0.94-1.36) 0.87 (0.71-1.07)
No 810 295 (36) Ref Ref
Generator13 025/0.563
Yes 187 88 (47) 1.47 (1.05-2.07) 1.14 (0.73-1.80)
No 2753 1036 (38) Ref Ref
Bandim Health Project, Guinea-Bissau, 2010-birth cohort.
1Standard error adjusted for clustering by robust variance estimates.
2Numbers do not add up due to some not living with their mother.
3Education of caretaker per year’s schooling; linear.
4100 had missing information on years of schooling.
5When including ethnic group rather than region in the final model the estimates changed less than 10% for all parameters assessed.
63 had missing information on ethnic group.
7160 had missing information on place of birth.
8370 had missing information on prenatal consultations.
935 had missing information on type of roof.
1044 had missing information on possession of a latrine.
1170 had missing information on possession of a cell phone.
1270 had missing information on possession of a radio.
1344 had missing information on possession of a generator.
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factors (Table 3). When the visit frequency was increased
to monthly visits (n = 1665) socioeconomic factors and
contact with the healthcare system were no longer signifi-
cantly associated with BCG coverage, only region was
significantly associated with BCG coverage in the multi-
variable analysis (Table 3).Information about reasons for not being BCG vaccinated
The year following implementation of monthly visits in
intervention regions, 1470 interviews were conducted with
mothers of BCG unvaccinated children from all regions.
Among the mothers 229 (16%) reported to have sought
vaccination for their child, 135 (59%) recalled to be told to
return another day to get the vaccine, and 76 (33%) had re-
ceived other vaccines (Additional file 3). Among the 1239
mothers, who reported not to have sought vaccination, 760
(61%) reported that their main reason was lack of money
whereas 481 (39%) said that the distance to the vaccination
post kept them from seeking vaccination (Additional file 3).Discussion
Main findings
In 2010, BCG coverage by 1 week of age was only 11% in
rural Guinea-Bissau. By 1 month of age the coverage was
38%, increasing to 73% by 3 months of age and 92% by 12
months of age. Contact with the health system was one of
the main factors associated with BCG vaccination, but so-
cioeconomic factors also played a role. When monthly visits
were introduced in intervention regions and BCG was
available for all children the inequity was reduced and the
1-month BCG coverage was 88% compared with 51% in
control regions.Strengths and weaknesses
A major strength of this study is the set-up in the form
of the health and demographic surveillance system cov-
ering a representative part of the population in rural
Guinea-Bissau. Data was collected through frequent
home visits by experienced field workers. Weaknesses
include that children who died before the assessment
age did not enter the coverage analysis; however, chil-
dren dying before 12 months of age usually do not enter
the standard coverage estimation either. Also it should
be noted that the vaccination coverage was estimated
using slightly different approaches in the 2010-birth co-
hort and the 2012 cohort. However, we do not directly
compare coverage between the cohorts, but only com-
pare coverage between intervention and control regions
within the 2012 cohort. Information on reasons for not
being vaccinated was collected based on the mothers’
recall.Consistency with other studies
Vaccination coverage is usually reported by 12 months of
age. We found 92% BCG coverage by 12 months in 2010,
which corroborates the 94% coverage from 2009 reported
by WHO [21]. Others have found that the median vaccin-
ation coverage across 31 low- and middle-income coun-
tries was 98% and ranged from 56% to 100% [19].
We found a much lower coverage by 1 and 3 months,
which concurs with reports of a median coverage across
the 31 countries of 65% by age of 4.3 weeks, ranging from
15% to 97% [19]. This supports the need for assessing
BCG coverage at earlier ages to disclose the delay in BCG
vaccination.
Other studies [22-24] defined timely BCG vaccination as
vaccinated before 8 weeks of age. The percentage of timely
vaccinated children ranged from 69% vaccinated [22] in a
large survey in 45 low-income and middle-income coun-
tries, to 99% [24] in a study from three areas in South Af-
rica. This still does not fully disclose the poor coverage in
the neonatal period, with only 49% coverage by 4 weeks
[22], quite similar to the 1-month coverage of 38% in the
present study.
We found that giving birth at a hospital or health centre
increased the likelihood of being BCG vaccinated. Simi-
larly, a study from South Africa found that birth at a
health facility reduced the risk of being unvaccinated by
47% (26%-42%) [24]. In Ethiopia there was also higher
BCG coverage for those born at a health facility [25]. In
Guinea-Bissau it is not general practice that children born
at a hospital or health centre are vaccinated before they
leave the health facility, however, they are often told to re-
turn to the health centre for vaccination.
It has previously been reported from South Africa [24]
and 31 low- and middle-income countries [19] that low
socioeconomic status was related to delay in BCG vac-
cination. We found a similar tendency, especially during
the first month of life. Importantly, this inequity in get-
ting BCG vaccinated was no longer apparent when we
provided BCG at monthly village visits.
Interpretation and implications
WHO vaccination coverage estimates are reported as the
coverage by 12 months of age not taking into account the
timeliness of vaccines received. This does not disclose de-
lays in administration of the BCG vaccine. It has been
shown that BCG vaccination can reduce neonatal mortal-
ity by 48% in LBW children when administered at birth
[6]. When donors only ask for BCG coverage by 12
months of age, there is no incentive to provide BCG in
the neonatal period. Therefore the 1-month coverage or
the median age at vaccination would be better indicators
of BCG coverage and its likely effect on child survival.
Obstacles to timely BCG were identified through the
interview with mothers of unvaccinated children. Among
Table 3 Factors associated with BCG vaccination by 1 month of age after implementation of monthly visits in intervention regions


















Gender2 0.492 / 0.662 0.099/0.070
Male 658 (77) Ref Ref 284 (50) Ref Ref
Female 620 (76) 0.93 (0.75-1.15) 1.05 (0.84-1.32) 260 (45) 0.82 (0.65-1.04) 0.78 (0.59-1.02)
Age of mother3 0.582 / 0.615 0.998/0.979
1.quartile (<21) 339 (78) Ref Ref 125 (47) Ref Ref
2. quartile (21–26) 244 (78) 1.01 (0.68-1.49) 0.95 (0.59-1.53) 113 (47) 1.00 (0.69-1.47) 1.09 (0.69-1.71)
3. quartile (27–31) 357 (76) 0.90 (0.64-1.27) 0.86 (0.60-1.25) 153 (48) 1.01 (0.71-1.45) 1.03 (0.65-1.63)
4. quartile (>31) 335 (75) 0.83 (0.59-1.17) 0.80 (0.53-1.22) 153 (48) 1.03 (0.75-1.40) 1.07 (0.72-1.59)
Education of
caretaker4, 5
0.003 / 0.377 0.018/0.771
None 607 (73) 1.08 (1.03-1.14) 1.03 (0.96-1.10) 317 (46) 1.07 (1.01-1.13) 0.99 (0.92-1.07)
1-4 years 323 (79) 118 (47)
5+ years 270 (83) 84 (59)
Region6 <0.001 / 0.002 0.003/0.161
Oio 271 (70) 0.67 (0.46-0.95) 0.70 (0.49-1.02) 81 (40) 0.49 (0.31-0.77) 0.67 (0.40-1.09)
Biombo 528 (81) 1.21 (0.87-1.68) 1.34 (0.91-1.98) 42 (47) 0.67 (0.41-1.11) 0.92 (0.56-1.51)
Gabu NA NA 83 (40) 0.50 (0.31-0.82) 0.63 (0.36-1.10)
Cacheu 479 (77) Ref Ref 148 (57) Ref Ref
Bafata NA NA 42 (39) 0.48 (0.27-0.88) 0.54 (0.30-0.98)
Quinara NA NA 112 (57) 1.01 (0.59-1.73) 1.18 (0.68-2.04)
Tombali NA NA 24 (37) 0.44 (0.17-1.15) 0.69 (0.26-1.89)
Bubaque NA NA 6 (60) 1.13 (0.43-2.95) 1.61 (0.43-6.07)
Bolama NA NA 7 (70) 1.75 (0.52-5.94) 1.82 (0.30-10.99)
Ethnic group7 0.109 / NA <0.001/NA
Balanta 401 (73) Ref 124 (41) Ref
Mandinga/Fula 194 (76) 1.18 (0.81-1.73) 175 (39) 0.92 (0.66-1.28)
Manjaco 140 (79) 1.37 (0.79-2.38) 64 (67) 2.84 (1.49-5.40)
Pepel 426 (81) 1.60 (1.12-2.27) 35 (48) 1.31 (0.80-2.13)



















Table 3 Factors associated with BCG vaccination by 1 month of age after implementation of monthly visits in intervention regions (Continued)
Contact with the
health system
Birth place8 0.369 / 0.515 <0.001/<0.001
At home 793 (76) Ref Ref 337 (43) Ref Ref
Healthcare centre 255 (81) 1.38 (0.95-1.99) 1.30 (0.83-2.03) 82 (53) 1.48 (1.01-2.16) 1.15 (0.76-1.74)
Hospital 192 (78) 1.17 (0.83-1.66) 0.96 (0.64-1.44) 106 (62) 2.18 (1.54-3.08) 1.81 (1.20-2.73)
Prenatal
consultations9
0.410 / 0.504 0.057/0.558
Yes 1093 (79) 1.16 (0.81-1.66) 0.86 (0.55-1.34) 460 (49) 1.55 (0.99-2.44) 1.20 (0.71-2.05)
No 124 (76) Ref Ref 42 (38) Ref Ref
Socioeconomics
Type of roof10 0.048 / 0.128 <0.001/<0.001
Straw 493 (74) Ref Ref 151 (37) Ref Ref
Hard 777 (79) 1.35 (1.00-1.83) 1.28 (0.93-1.77) 386 (54) 1.97 (1.50-2.58) 1.74 (1.30-2.32)
Toilet11 0.039 / 0.188 0.136/0.706
None 445 (74) Ref Ref 100 (44) Ref Ref
Latrine/ toilet in
house
819 (79) 1.32 (1.01-1.73) 1.24 (0.90-1.71) 439 (49) 1.23 (0.94-1.62) 0.93 (0.67-1.30)
Household
possessions
Cell phone12 0.011 / 0.136 0.009/0.347
Yes 747 (80) 1.38 (1.08-1.78) 1.25 (0.93-1.66) 311 (51) 1.39 (1.08-1.79) 1.15 (0.84-1.55)
No 501 (74) Ref Ref 221 (43) Ref Ref
Radio13 0.183 / 0.303 0.159/0.841
Yes 958 (78) 1.21 (0.91-1.59) 1.17 (0.87-1.56) 422 (49) 1.24 (0.92-1.67) 1.05 (0.75-1.48)



















Table 3 Factors associated with BCG vaccination by 1 month of age after implementation of monthly visits in intervention regions (Continued)
Generator14 0.020 / 0.083 0.234/0.636
Yes 149 (83) 1.51 (1.07-2.13) 1.46 (0.95-2.24) 53 (53) 1.27 (0.86-1.87) 0.89 (0.54-1.47)
No 1115 (76) Ref Ref 485 (47) Ref Ref
Bandim Health Project, Guinea-Bissau, 2012 cohort.
1Standard error adjusted for clustering by robust variance estimates.
21 had missing information on gender.
3Numbers do not add up due to some not living with their mother.
4Education of caretaker per year’s schooling; linear.
5157 had missing information on years of schooling.
6When including ethnic group rather than region in the final model the estimates changed less than 10% for all parameters assessed.
73 had missing information on ethnic group.
856 had missing information on place of birth, 26 were born elsewhere and have been excluded due to small numbers.
9202 had missing information on prenatal consultations.
1033 had missing information on type of roof.
1136 had missing information on possession of a latrine.
1271 had missing information on possession of a cell phone.
1358 had missing information on possession of a radio.
1437 had missing information on possession of a generator.
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http://www.biomedcentral.com/1471-2458/14/1037the mothers having sought vaccination but had not ob-
tained BCG more than half the mothers recalled being told
to return another day. We speculate that the restricted vial-
opening policy is one of the main obstacles to early BCG
vaccination but the information disclosed to the mothers
does not allow any final conclusion. Among the mothers
who had not sought vaccination not having money and dis-
tance to health facility were the main obstacles to taking
their child for vaccination. Routine childhood vaccinations
are provided free of charge in Guinea-Bissau, but health
workers charge fees (~1$) for vaccination cards.
Twenty-five percent of BCG unvaccinated children had
been in contact with a health facility by 1 month of age.
The potential coverage by 1 month of age was 54% in 2010,
if all children had been BCG vaccinated at first contact with
the health system. Monthly village visits with BCG vaccin-
ation for all children significantly increased BCG vaccin-
ation coverage, especially at early ages, and would provide a
very efficient tool for increasing especially coverage among
the youngest children.
Conclusions
Our study showed a large delay in BCG vaccination in
Guinea-Bissau with less than half of the children being
BCG vaccinated by 1 month and only 11% being BCG
vaccinated by 1 week of age. Our risk factor analysis
identified many factors associated with delay of BCG
vaccination, including a number of socioeconomic fac-
tors, but these factors were no longer associated with
delayed BCG vaccination when BCG-vaccination be-
came available to all children at monthly visits.
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